138 related articles for article (PubMed ID: 38081200)
21. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
23. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?
Tajima T; Akahane M; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Kokudo N; Ohtomo K
Jpn J Radiol; 2012 Oct; 30(8):648-58. PubMed ID: 22836904
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
25. Use of liver magnetic resonance imaging after standard staging abdominopelvic computed tomography to evaluate newly diagnosed colorectal cancer patients.
Han K; Park SH; Kim KW; Kim HJ; Lee SS; Kim JC; Yu CS; Lim SB; Joo YS; Kim AY; Ha HK
Ann Surg; 2015 Mar; 261(3):480-6. PubMed ID: 24866542
[TBL] [Abstract][Full Text] [Related]
26. Utility of combined gadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative detection of colorectal cancer liver metastases: a pilot study.
Carney BW; Gholami S; Fananapazir G; Sekhon S; Lamba R; Loehfelm TW; Wilson MD; Corwin MT
Acta Radiol; 2023 Apr; 64(4):1357-1362. PubMed ID: 36437569
[TBL] [Abstract][Full Text] [Related]
27. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of abbreviated gadoxetic acid-enhanced magnetic resonance protocols with contrast-enhanced computed tomography for detection of colorectal liver metastases.
Ozaki K; Ishida S; Higuchi S; Sakai T; Kitano A; Takata K; Kinoshita K; Matta Y; Ohtani T; Kimura H; Gabata T
World J Radiol; 2022 Oct; 14(10):352-366. PubMed ID: 36340439
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection.
Bhattacharjya S; Bhattacharjya T; Baber S; Tibballs JM; Watkinson AF; Davidson BR
Br J Surg; 2004 Oct; 91(10):1361-9. PubMed ID: 15376205
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic performance of
Samim M; Molenaar IQ; Seesing MFJ; van Rossum PSN; van den Bosch MAAJ; Ruers TJM; Borel Rinkes IHM; van Hillegersberg R; Lam MGEH; Verkooijen HM
Surg Oncol; 2017 Mar; 26(1):37-45. PubMed ID: 28317583
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE
Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.
Litjens G; Rivière DM; van Geenen EJM; Radema SA; Brosens LAA; Prokop M; van Laarhoven CJHM; Hermans JJ
BMC Cancer; 2020 Aug; 20(1):744. PubMed ID: 32778061
[TBL] [Abstract][Full Text] [Related]
34. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
35. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
36. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
[TBL] [Abstract][Full Text] [Related]
37. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Kong G; Jackson C; Koh DM; Lewington V; Sharma B; Brown G; Cunningham D; Cook GJ
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1323-9. PubMed ID: 18347794
[TBL] [Abstract][Full Text] [Related]
38. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
Kuehl H; Antoch G; Stergar H; Veit-Haibach P; Rosenbaum-Krumme S; Vogt F; Frilling A; Barkhausen J; Bockisch A
Eur J Radiol; 2008 Aug; 67(2):362-371. PubMed ID: 18155866
[TBL] [Abstract][Full Text] [Related]
39. Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.
Saing S; Haywood P; Duncan JK; Ma N; Cameron AL; Goodall S
ANZ J Surg; 2018 Jun; 88(6):E507-E511. PubMed ID: 28982209
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
